Russia, the world's largest supplier of enriched uranium, said today that it had imposed temporary restrictions on the export of enriched uranium to the United States. Russia has 44% of the world's uranium enrichment capacity and 35% of U.S. nuclear fuel imports used to come from Russia, according to the national data. After this information, the biggest US-based uranium enrichment company Centrus Energy (LEU.US) drops 5.5%, while the largest US based uranium miner Uranium Energy Corp (UEC.US) surges 8%, awaiting to profit from higher spot uranium prices, supported by trade restrictions between US and Russia.
Source: xStation5
Daily Summary – Wall Street Rises Ahead of “Magnificent Seven” Earnings
Palantir and Nvidia Join Forces in Advanced Artificial Intelligence Development
Microsoft and OpenAI: Strategic Restructuring and the Upcoming Report as an AI Market Barometer
Cameco Shares Hit Record Highs Following Strategic Partnership Announcement with the US!
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
